GlassScriptPhysician profile
Louis H Eichel
NPI 1588689772
$10,047.25
in general payments reported to CMS, 2019-2025
38 companies · $617 in 2025
The $617 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $355 · 2021: $475 · 2022: $6,340 · 2023: $1,173 · 2024: $672 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,461.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $5,744.08 | 2021-2022 | |
| Edap Technomed INC | $930.43 | 2020-2024 | |
| Astellas Pharma US INC | $476.62 | 2019-2025 | Xtandi |
| Olympus America INC. | $336.02 | 2022-2025 | Itind System |
| Procept Biorobotics Corporation | $307.58 | 2019-2023 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $264.94 | 2021-2025 | Erleada |
| Pfizer INC. | $240.86 | 2019-2025 | |
| Intuitive Surgical, INC. | $212.01 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $186.06 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $183.04 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $122.33 | 2021-2024 | Interstim |
| Organogenesis INC. | $94.00 | 2019 | |
| Calyxo, INC. | $81.08 | 2024 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $80.49 | 2024-2025 | Bard Urinary Drainage Bag |
| Biotissue Holdings INC. | $75.94 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $73.58 | 2022-2025 | |
| Medtronic USA, INC. | $59.41 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $57.64 | 2020-2023 | Prolaris |
| Urogen Pharma, INC. | $55.38 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.22 | 2020-2025 | |
| Axonics, INC. | $38.47 | 2023 | Bulkamid |
| Tolmar, INC. | $37.00 | 2025 | Jatenzo, Eligard |
| Merck Sharp & Dohme LLC | $33.09 | 2020-2021 | |
| Zyla Life Sciences, INC. | $31.74 | 2019-2020 | |
| Allergan, INC. | $28.21 | 2019-2021 | |
| Baxter Healthcare | $27.44 | 2024 | Floseal |
| Ambu INC. | $26.25 | 2020 | |
| Boston Scientific Corporation | $22.44 | 2022 | |
| Antares Pharma, INC. | $22.16 | 2022 | |
| Amniox Medical, INC. | $21.43 | 2020 | |
| Progenics Pharmaceuticals, INC. | $20.90 | 2022 | |
| Agiliti Surgical, INC. | $20.41 | 2023 | Trinity |
| Janssen Scientific Affairs, LLC | $20.11 | 2019 | |
| Neotract INC. | $18.25 | 2020 | |
| Ferring Pharmaceuticals INC. | $18.14 | 2019 | |
| Novo Nordisk INC | $16.02 | 2024 | Rivfloza |
| Tolmar Pharmaceuticals, INC. | $13.38 | 2020 | |
| Janssen Pharmaceuticals, INC | $10.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Eichel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.